Anika Therapeutics Inc
ANIK9.750USD
-0.100-1.02%
Fechamento 11/06, 16:00（ET）Cotações atrasadas em 15 min
140.58MValor de mercado
PerdaP/L TTM
Mais detalhes de Anika Therapeutics Inc Empresa
Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.
Informações de Anika Therapeutics Inc
Código da empresaANIK
Nome da EmpresaAnika Therapeutics Inc
Data de listagemMay 16, 1985
CEODr. Cheryl Renee Blanchard, Ph.D.
Número de funcionários288
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 16
Endereço32 Wiggins Ave
CidadeBEDFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal01730-2315
Telefone17814579000
Sitehttps://anika.com/
Código da empresaANIK
Data de listagemMay 16, 1985
CEODr. Cheryl Renee Blanchard, Ph.D.
Executivos da empresa Anika Therapeutics Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
Mr. Ian McLeod
Mr. Ian McLeod
Chief Accounting Officer, Vice President, Treasurer
Chief Accounting Officer, Vice President, Treasurer
--
--
Mr. Gary P. Fischetti
Mr. Gary P. Fischetti
Independent Director
Independent Director
--
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
OEM Channel
16.34M
57.90%
Commercial Channel
11.88M
42.10%
Por RegiãoUSD
Nome
Receita
Proporção
United States
17.92M
63.52%
Other
5.54M
19.64%
Europe
4.75M
16.84%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
OEM Channel
16.34M
57.90%
Commercial Channel
11.88M
42.10%
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Trigran Investments, Inc.
14.12%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.41%
Dimensional Fund Advisors, L.P.
4.32%
Outro
59.69%
Investidores
Investidores
Proporção
Trigran Investments, Inc.
14.12%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.41%
Dimensional Fund Advisors, L.P.
4.32%
Outro
59.69%
Tipos de investidores
Investidores
Proporção
Hedge Fund
37.86%
Investment Advisor/Hedge Fund
27.04%
Investment Advisor
23.18%
Individual Investor
4.88%
Research Firm
1.06%
Pension Fund
0.45%
Bank and Trust
0.13%
Insurance Company
0.03%
Outro
5.37%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
261
13.09M
90.76%
-1.17M
2025Q2
302
13.74M
95.32%
-1.50M
2025Q1
310
13.52M
94.22%
-1.59M
2024Q4
308
13.33M
91.05%
-2.02M
2024Q3
309
13.98M
94.53%
-1.95M
2024Q2
313
14.09M
95.06%
-2.05M
2024Q1
312
14.07M
96.09%
-1.66M
2023Q4
314
13.84M
94.50%
-1.88M
2023Q3
309
13.57M
92.73%
-2.13M
2023Q2
310
13.73M
93.04%
-2.32M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Trigran Investments, Inc.
2.04M
14.12%
-5.34K
-0.26%
Jun 30, 2025
Caligan Partners, LP
1.44M
9.95%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
937.30K
6.5%
-20.13K
-2.10%
Jun 30, 2025
The Vanguard Group, Inc.
779.47K
5.41%
+2.07K
+0.27%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
623.08K
4.32%
+9.11K
+1.48%
Jun 30, 2025
Opaleye Management Inc.
588.80K
4.08%
+193.80K
+49.06%
Jun 30, 2025
Acadian Asset Management LLC
575.64K
3.99%
+36.03K
+6.68%
Jun 30, 2025
The Capital Management Corporation
408.85K
2.84%
+79.19K
+24.02%
Jun 30, 2025
BlackRock Financial Management, Inc.
546.12K
3.79%
+24.11K
+4.62%
Jun 30, 2025
Boothbay Fund Management, LLC
529.50K
3.67%
--
--
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: há 20 horas
Atualizado em: há 20 horas
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
0.48%
Royce Quant Small-Cap Quality Value ETF
0.21%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.09%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
iShares Russell 2000 Value ETF
0.01%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção0.48%
Royce Quant Small-Cap Quality Value ETF
Proporção0.21%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporção0.09%
iShares Micro-Cap ETF
Proporção0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporção0.01%
Avantis US Small Cap Equity ETF
Proporção0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.01%
WisdomTree US SmallCap Fund
Proporção0.01%
iShares Russell 2000 Value ETF
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
